These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18430219)

  • 21. Competition, payers, and hospital quality.
    Gozvrisankaran G; Town RJ
    Health Serv Res; 2003 Dec; 38(6 Pt 1):1403-21. PubMed ID: 14727780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Avoiding antitrust compliance difficulties in mergers and acquisitions.
    Bryant LE
    Healthc Financ Manage; 1993 Aug; 47(8):48-50, 52, 54-8. PubMed ID: 10145853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding the impact of Federal Trade Commission v. Tenet Healthcare Corporation.
    Becker S
    Health Care Law Mon; 1998 Dec; ():18-23. PubMed ID: 10346230
    [No Abstract]   [Full Text] [Related]  

  • 24. The changing effects of competition on non-profit and for-profit hospital pricing behavior.
    Keeler EB; Melnick G; Zwanziger J
    J Health Econ; 1999 Jan; 18(1):69-86. PubMed ID: 10338820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of geographic market definition on the stringency of hospital merger control in Germany and the Netherlands.
    Varkevisser M; Schut FT
    Health Econ Policy Law; 2012 Jul; 7(3):363-81. PubMed ID: 22348390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitrust, health care quality, and the courts.
    Hammer PJ; Sage WM
    Columbia Law Rev; 2002 Apr; 102(3):545-649. PubMed ID: 11985363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimizing antitrust exposure in a virtual merger.
    Brock TH
    Healthc Financ Manage; 1999 Sep; 53(9):38-44. PubMed ID: 11066705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Market-based solutions to antitrust threats--the rejection of the Partners settlement.
    Herzlinger RE; Richman BD; Schulman KA
    N Engl J Med; 2015 Apr; 372(14):1287-9. PubMed ID: 25738542
    [No Abstract]   [Full Text] [Related]  

  • 29. Antitrust treatment of hospital mergers.
    Blair RD; Fesmire JM
    Spec Law Dig Health Care (Mon); 1991 May; (147):7-37. PubMed ID: 10110489
    [No Abstract]   [Full Text] [Related]  

  • 30. Purchase of OrNda adds bulk to No. 2 chain Tenet.
    Shinkman R; Japsen B; Morrissey J
    Mod Healthc; 1996 Oct; 26(43):2-3, 16. PubMed ID: 10162881
    [No Abstract]   [Full Text] [Related]  

  • 31. Which types of hospital mergers save consumers money?
    Connor RA; Feldman RD; Dowd BE; Radcliff TA
    Health Aff (Millwood); 1997; 16(6):62-74. PubMed ID: 9444809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health Care Efficiencies: Consolidation and Alternative Models vs. Health Care and Antitrust Regulation - Irreconcilable Differences?
    King MW
    Am J Law Med; 2017 Nov; 43(4):426-467. PubMed ID: 29452560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The competitive effects of horizontal mergers in the hospital industry.
    Woolley JM
    J Health Econ; 1989 Dec; 8(3):271-91. PubMed ID: 10296709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should not-for-profit organizations be exempt from antitrust laws?
    Bryant LE
    Healthc Financ Manage; 1988 Jun; 42(6):70-2, 76-80, 84-5. PubMed ID: 10287603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The need for an antitrust policy for a health care industry in transition.
    Zwanziger J
    J Health Polit Policy Law; 1995; 20(1):171-3. PubMed ID: 7738316
    [No Abstract]   [Full Text] [Related]  

  • 36. Antitrust guidelines' first test benefits for-profit chain.
    Burda D
    Mod Healthc; 1994 Feb; 24(7):2-3. PubMed ID: 10131769
    [No Abstract]   [Full Text] [Related]  

  • 37. The competitive effects of horizontal mergers in the hospital industry: a closer look.
    Vita MG; Schumann L
    J Health Econ; 1991 Oct; 10(3):359-72. PubMed ID: 10114572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health care consolidation and the changing health care marketplace. A review of the literature and issues.
    Goldberg LG
    EBRI Issue Brief; 1999 Oct; (214):1-15. PubMed ID: 10622866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HMO mergers: estimating impact on premiums and costs.
    Christianson JB; Feldman RD; Wholey DR
    Health Aff (Millwood); 1997; 16(6):133-41. PubMed ID: 9444820
    [No Abstract]   [Full Text] [Related]  

  • 40. Hospitals and antitrust: defining markets, setting standards.
    Zwanziger J; Melnick G; Eyre KM
    J Health Polit Policy Law; 1994; 19(2):423-47. PubMed ID: 8077637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.